← All stocks

Boston Scientific

BSX Net selling
CIK 0000885725 #76 in the set updated 17 Sep 2026
Bought (120 mo)
$11.10M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$559.74M
$24.34M on a plan · $445.99M straight out of an exercise
Sold at will
$89.40M
180 of 430 sales
Net
−$548.64M
−$78.31M against sales at will

By person

42 insiders · 447 transactions
55.0×

Michael F. Mahoney holds 55.0 times base salary in stock. $79.35M of shares against $1.44M in salary for 2025.

Salary from the company's own proxy. The shares are what Michael F. Mahoney last reported holding, valued at $49.22, the price Common Stock was last bought or sold at on the open market here, on 25 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mahoney Michael F
Chairman, President & CEO
$9.00M (1)
$210.83M (29) scheduled
−$201.83M
1,612,143
0.1112%
$79.35M
+20.7%
Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
$4.51K (1)
$75.17M (25) scheduled
−$75.17M
278,105
0.0192%
$13.69M
+91.2%
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
$60.26M (23) scheduled
−$60.26M
77,092
0.0053%
$3.79M
+347.1%
Brennan Daniel J.
EVP and CFO
$43.38M (26) scheduled
−$43.38M
225,808
0.0156%
$11.11M
+47.3%
Mirviss Jeffrey B.
EVP&Pres, Periph Intervent
$29.78M (39) scheduled
−$29.78M
25,766
0.0018%
$1.27M
−65.3%
Carruthers Wendy
EVP, Human Resources
$20.71M (45) scheduled
−$20.71M
29,308
0.0020%
$1.44M
−67.3%
Thepaut Eric Francis Yves
EVP & Pres, Eur, Mid-East, Afr
$14.70M (13)
−$14.70M
31,422
0.0022%
$1.55M
−73.3%
Pierce David A
EVP Pres MedSurg
$14.18M (71) scheduled
−$14.18M
0
0.0000%
$0.00
−100.0%
Nanavaty Maulik
SVP & Pres, Neuromodulation
$13.62M (21) scheduled
−$13.62M
177,258
0.0122%
$8.72M
−1.7%
Sorenson John Bradley
EVP, Global Operations
$11.91M (30) scheduled
−$11.91M
18,705
0.0013%
$920.65K
+48.3%
Bose Supratim
EVP & President, Asia-Pacific
$10.11M (2) scheduled
−$10.11M
320,301
0.0221%
$15.77M
+29.1%
Ballinger Kevin J.
EVP & Pres, Interven Cardio
$9.46M (17) scheduled
−$9.46M
80,085
0.0055%
$3.94M
+56.6%
Phalen Michael P.
EVP & President, MedSurg
$6.65M (11) scheduled
−$6.65M
133,373
0.0092%
$6.56M
+46.0%
Mackey Edward F
EVP, Operations
$6.38M (3)
−$6.38M
52,944
0.0037%
$2.61M
+267.5%
Brown Vance R
EVP, GC and Corp. Secretary
$5.26M (7) scheduled
−$5.26M
54,244
0.0037%
$2.67M
+97.7%
Pratt Timothy A.
EVP, GC & Chief Admin Officer
$4.97M (15)
−$4.97M
154,681
0.0107%
$7.61M
−39.7%
Zane Ellen M
Director
$3.99M (4) scheduled
−$3.99M
27,934
0.0019%
$1.37M
+212.7%
LUDWIG EDWARD J
Director
$430.31K (2)
$3.73M (6)
−$3.30M
30,359
0.0021%
$1.49M
+45.8%
Dawkins Keith D
EVP, Global Chief Med. Off.
$2.78M (2)
−$2.78M
68,165
0.0047%
$3.36M
−54.6%
Woodworth Emily
SVP, Global Controller and CAO
$1.92M (4) scheduled
−$1.92M
5,789
0.0004%
$284.93K
+26.6%
Wang Xin Warren
SVP and Pres, Asia Pacific
$1.53M (4)
−$1.53M
78,985
0.0055%
$3.89M
−16.1%
Connors Nelda J
Director
$1.48M (2)
−$1.48M
36,069
0.0025%
$1.78M
+11.6%
Monson Jonathan
EVP and CFO
$1.41M (5) scheduled
−$1.41M
48,971
0.0034%
$2.41M
+85.9%
Eddy Jodi Euerle
SVP, Chief Info & Digital Off.
$1.36M (8)
−$1.36M
23,263
0.0016%
$1.14M
+35.5%
Scanlon Meghan
SVP,Pres,Urology Pelvic Health
$1.35M (2) scheduled
−$1.35M
24,461
0.0017%
$1.20M
+185.1%
Dockendorff Charles J
Director
$1.15M (2) scheduled
−$1.15M
2,901
0.0002%
$142.79K
WICHMANN DAVID S
Director
$1.05M (1)
+$1.05M
45,382
0.0031%
$2.23M
Meredith Ian T
EVP Global Chief Med Officer
$591.01K (2)
−$591.01K
28,082
0.0019%
$1.38M
+3,866%
FUJIMORI YOSHIAKI
Director
$538.47K (2)
−$538.47K
2,081
0.0001%
$102.43K
−66.1%
Habiger David C
Director
$407.92K (5)
+$407.92K
17,160
0.0012%
$844.61K
+12,157%
Ralls-Morrison Desiree
SVP, GC and Corp Secretary
$376.07K (3)
−$376.07K
29,909
0.0021%
$1.47M
+1,278%
Olson Scott
SVP & Pres, CRM, Diagnostics
$173.67K (6)
−$173.67K
14,518
0.0010%
$714.57K
+23.6%
Morano Susan E
Director
$100.41K (1)
+$100.41K
13,784
0.0010%
$678.44K
Pegus Cheryl
Director
$99.99K (1)
+$99.99K
1,770
0.0001%
$87.12K
Sununu John E
Director
$1.93K (3)
$2.51K (1)
−$579.06
54,723
0.0038%
$2.69M
+319.5%
ROUX DAVID J
Director
73,591
0.0051%
$3.62M
+99.5%
JAMES DONNA
Director
21,879
0.0015%
$1.08M
+149.8%
O'Sullivan Miriam
SVP, Chief HR Officer
19,033
0.0013%
$936.79K
+38.5%
Mega Jessica L
Director
12,035
0.0008%
$592.36K
MACMILLAN STEPHEN P
Director
8,000
0.0006%
$393.76K
+743.9%
O'Connor Padraig Andrew
EVP, Global Operations
7,892
0.0005%
$388.44K
+90.2%
Weber Christophe Pierre
Director
3,786
0.0003%
$186.35K
Insider
Date
Role
Action
Shares
Price
Amount
Morano Susan E
25 Aug 2026
Director
Buy
2,040
$49.22
$100.41K
Habiger David C
5 Aug 2026
Director
Buy
2,100
$47.59
$99.94K
Habiger David C
4 Aug 2026
Director
Buy
140
$48.59
$6.80K
Mahoney Michael F
3 Aug 2026
Chairman, President & CEO
Buy
186,240
$48.33
$9.00M
Habiger David C
3 Aug 2026
Director
Buy
1,042
$48.07
$50.08K
LUDWIG EDWARD J
31 Jul 2026
Director
Buy
5,000
$45.48
$227.40K
Habiger David C
20 May 2026
Director
Buy
2,250
$55.92
$125.82K
LUDWIG EDWARD J
20 May 2026
Director
Buy
3,580
$56.68
$202.91K
Pegus Cheryl
20 May 2026
Director
Buy
1,770
$56.49
$99.99K
Habiger David C
19 May 2026
Director
Buy
2,200
$56.95
$125.28K
Fitzgerald Joseph Michael
3 Dec 2024
EVP & Group Pres, Cardiology
Buy
50
$90.29
$4.51K
WICHMANN DAVID S
15 Nov 2021
Director
Buy
25,000
$41.98
$1.05M
Showing 250 of 447 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 1,256
Amendments (4/A) skipped 7
Filings about a different issuer 4
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 215
Sales at will 180
Transactions with no price 0
Shares from compensation/vesting 20,769,206
Sales filed before the plan box existed 165
History held since 6 Sep 2016